Innovir, VimRx deal

The companies entered an agreement under which VMRX would acquire a 66 percent interest in INVR in return for

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE